- Release Date: 18/10/21 09:48
- Summary: Remestemcel-L Improves Survival in High-Risk Acute GvHD
- Price Sensitive: No
- Download Document 189.84KB
Ann: Remestemcel-L Improves Survival in High-Risk Acute GvHD
- There are more pages in this discussion • 116 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
-0.105(8.54%) |
Mkt cap ! $1.321B | |||
| Open | High | Low | Value | Volume |
| $1.20 | $1.20 | $1.13 | $9.969M | 8.605M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 13209 | $1.13 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 157020 | 18 |
View Market Depth
| Last trade - 13.40pm 30/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.13 |
Change
-0.105 ( 8.47 %) |
||||
| Open | High | Low | Volume | ||
| $1.20 | $1.20 | $1.12 | 1164135 | ||
| Last updated 14.00pm 30/05/2024 ? | |||||
| MSB (ASX) Chart |